Clinical Trials Browser

Observational × Panitumumab × Clear all

NCT02394834 2025-05-09

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT03043950 2024-04-24

VALIDATE

Gastrointestinal

Colorectal Neoplasms

NCT01732783 2022-11-08

Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients

213 enrolled 30 charts

Gastrointestinal

Colorectal Neoplasms

NCT03923036 2019-04-22

AVOCETTE

Gastrointestinal

Colorectal Cancer Metastatic

NCT02089737 2017-04-06

Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance)

3,091 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms